Efficacy and safety of CDK4/6 inhibitors in combination with endocrine therapy for HR+/HER2- breast cancer: a meta-analysis

Authors
Category Systematic review
JournalChinese Journal of Evidence-Based Medicine
Year 2024
This article has no abstract
Epistemonikos ID: 4a75caf0f021d8712707cab81360ea3c96a1ebc6
First added on: Feb 17, 2025